# Rand Capital Corp: overview RAND · Nasdaq · CIK 81955 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rand.md) · [Financials](/companies/rand/financials.md) · [Filings](/companies/rand/filings.md) · [Insiders](/companies/rand/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.02](/filings/0001193125-26-133767.md) | [(1.14)](/filings/0001193125-26-133767.md) | [0.29](/filings/0001193125-26-207688.md) | [(2.60)](/filings/0001193125-26-333983.md) | [(0.75)](/filings/0001193125-26-133767.md) | [0.37](/filings/0001193125-26-133767.md) | [(0.12)](/filings/0001193125-26-207688.md) | [0.46](/filings/0001193125-26-333983.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [6.12](/filings/0000950170-24-025396.md) | [(0.34)](/filings/0000950170-25-035949.md) | [2.53](/filings/0001193125-26-133767.md) | [3.42](/filings/0001193125-26-133767.md) | [(2.73)](/filings/0001193125-26-133767.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rand/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [COURIER CAPITAL LLC](/funds/1015247.md) | 2026-06-30 | $156.9k | 15,382 | | Unchanged | | [SHUFRO ROSE & CO LLC](/funds/908195.md) | 2026-06-30 | $142.8k | 14,000 | | Unchanged | | [WNY Asset Management, LLC](/funds/1803296.md) | 2026-06-30 | $135.2k | 13,250 | | New +13,250 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $22.9k | 2,242 | | New +2,242 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $22.8k | 2,237 | | Added +1,490 | | [Bullock Wealth Management Group](/funds/2067581.md) | 2026-06-30 | $6.6k | 642 | | Not compared | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $18 | 1 | | Unchanged | | [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $7 | 1 | | Added +1 | ## Recent filings [All 480 filings](/companies/rand/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-05 | 08:45 ET | [10-Q](/filings/0001193125-26-333983.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333983 | | 2026-08-05 | 08:10 ET | [8-K](/filings/0001493152-26-036108.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036108 | | 2026-05-06 | 08:45 ET | [10-Q](/filings/0001193125-26-207688.md) | Quarterly report, period 2026-03-31 | 0001193125-26-207688 | | 2026-05-06 | 08:35 ET | [8-K](/filings/0001493152-26-021411.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-021411 | | 2026-04-23 | 16:30 ET | [8-K](/filings/0001493152-26-018722.md) | 5.07 Shareholder vote results | 0001493152-26-018722 | | 2026-03-31 | 12:00 ET | [10-K/A](/filings/0001193125-26-133767.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-133767 | | 2026-03-13 | 16:30 ET | [DEF 14A](/filings/0001493152-26-010075.md) | Proxy statement, period 2026-03-13 | 0001493152-26-010075 | | 2026-03-05 | 08:46 ET | [10-K](/filings/0001193125-26-092669.md) | Annual report, period 2025-12-31 | 0001193125-26-092669 | | 2026-03-05 | 08:05 ET | [8-K](/filings/0001493152-26-008935.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008935 | | 2025-11-07 | 08:45 ET | [10-Q](/filings/0001193125-25-271151.md) | Quarterly report, period 2025-09-30 | 0001193125-25-271151 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-092669.md), filed Mar 5, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 81955 - Tickers: RAND - Exchange: Nasdaq - SIC code: not reported - State of incorporation: NY - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.